This study is accepting new patients by invitation only

Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients

a study on HIV/AIDS

Summary

at UCLA
study started
estimated completion
Ronald Mitsuyasu (ucla)

Description

Summary

Long term safety follow-up of Cal-1 recipients

Official Title

Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced With LVsh5/C46, a Dual Anti-HIV Gene Transfer Construct

Details

Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced with LVsh5/C46 (Cal-1), a Dual Anti-HIV Gene Transfer Construct

Keywords

HIV-1 InfectionReceipt of Cal-1 Modified Hematopoietic Cellular ProductsBlood tests

Eligibility

You can join if…

  • Signed informed consent
  • Previous treatment with the Cal-1 modified hematopoietic cellular products

You CAN'T join if...

  • Inability to understand and provide informed consent

Locations

  • UCLA CARE Center
    Los AngelesCalifornia90035United States
  • Quest Clinical Research
    San FranciscoCalifornia94115United States

Lead Scientist

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
Calimmune, Inc.
ID
NCT02390297
Study Type
Observational
Last Updated